Cited by 27Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathologyCytokine Signaling Pathways and Interactions

ME3738 protects from concanavalin A‐induced liver failure via an IL‐6‐dependent mechanism

Open access
Klein, Christian, Wüstefeld, Torsten, Heinrich, Peter C., Streetz, Konrad L., Manns, Michael P., Trautwein, Christian·2003·European Journal of Immunology

Abstract

ME3738 is a new compound that attenuates liver disease in several models of acute and chronic liver inflammation. We used the concanavalin A (Con A) model to elucidate the molecular mechanismsof ME3738 to block liver cell damage. Pretreatment of BALB/c mice with ME3738 prior to Con A injection resulted in a significant reduction in liver injury. The protective effect of ME3738 prior to Con A injection was associated with a reduction in IL‐6 serum levels and NF‐κB DNA binding in liver nuclear extracts. However, STAT3 DNA binding was induced via ME3738 prior to Con A injection. Further analysis showed that ME3738 induces IL‐6 serum levels and activates STAT3 DNA binding and target gene transcription. The relevance of this finding was assessed in IL‐6–/– mice. Inthese animals, ME3738 induced no increase in IL‐6 serum expression, and activation of IL‐6‐dependent pathways was not found. In addition, ME3738 did not protect IL‐6–/– animals from Con A‐induced liver failure, while IL‐6 injection was still effective. Therefore, we demonstrate that ME3738 triggers IL‐6 expression, which activates pathways that are relevant to protect from Con A‐induced liver failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.200323651

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 36 · Cited by 27

Research works printed but not linked: 3

  1. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K., Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 2000. 97: 5498-5503.
  2. Doi, T. S., Marino, M. W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L. J. and Obata, Y., Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. USA 1999. 6: 2994-2999.
  3. Sambrook, J., Fritsch, E. F. and Maniatis, T. (Eds.) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Habor 1989.

Authors
Klein, C., Wüstefeld, T., Heinrich, P. C., Streetz, K. L., Manns, M. P., & Trautwein, C.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • RWTH Aachen University (DE)
Venue
European Journal of Immunology
Publisher
Wiley
Published
2003-07-14
Volume
33
Issue
8
Pages
2251-2261
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2058866971
Cited by
27
References
36
Citations by year
2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2013: 3
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • European Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft (SFB 566, Project B8)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
concanavalin A, liver failure, interleukin-6, STAT3, NF-κB, liver injury, hepatoprotection, IL-6 knockout mice, cytokine signaling, liver inflammation
MeSH terms
Acute-Phase Reaction, Animals, Concanavalin A, DNA-Binding Proteins, Immunosuppressive Agents, Male, Mice, Inbred BALB C, Oleanolic Acid, Tumor Necrosis Factor-alpha, Trans-Activators, Interleukin-6, Gene Expression, NF-kappa B, Liver Failure, Mice, Knockout, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review